Net profit of Windlas Biotech rose 11.62% to Rs 15.66 crore in the quarter ended September 2024 as against Rs 14.03 crore during the previous quarter ended September 2023. Sales rose 22.49% to Rs 187.00 crore in the quarter ended September 2024 as against Rs 152.67 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales187.00152.67 22 OPM %12.3312.24 - PBDT26.7921.64 24 PBT20.2918.31 11 NP15.6614.03 12 Powered by Capital Market - Live News

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live News

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live News

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live News

Net profit of Windlas Biotech rose 11.68% to Rs 13.48 crore in the quarter ended June 2024 as against Rs 12.07 crore during the previous quarter ended June 2023. Sales rose 20.97% to Rs 175.15 crore in the quarter ended June 2024 as against Rs 144.79 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales175.15144.79 21 OPM %11.9211.84 - PBDT24.5219.53 26 PBT18.3116.34 12 NP13.4812.07 12 Powered by Capital Market - Live News